Cashman Llp Pryor - Net Worth and Insider Trading

Cashman Llp Pryor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cashman Llp Pryor owns 1 companies in total, including Adhera Therapeutics Inc (ATRX) .

Click here to see the complete history of Cashman Llp Pryor’s form 4 insider trades.

Insider Ownership Summary of Cashman Llp Pryor

Ticker Comapny Transaction Date Type of Owner
ATRX Adhera Therapeutics Inc 2012-08-21 10 percent owner

Cashman Llp Pryor Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Cashman Llp Pryor Ownership Network

Ownership Network List of Cashman Llp Pryor

No Data

Ownership Network Relation of Cashman Llp Pryor

Insider Network Chart

Cashman Llp Pryor Owned Company Details

What does Adhera Therapeutics Inc do?

Who are the key executives at Adhera Therapeutics Inc?

Cashman Llp Pryor is the 10 percent owner of Adhera Therapeutics Inc. Other key executives at Adhera Therapeutics Inc include director & Chief Executive Officer Andrew Albert Kucharchuk , SVP Finance & Accounting Rhonda L. Stanley , and Chief Financial Officer Robert Eric Teague .

Adhera Therapeutics Inc (ATRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adhera Therapeutics Inc (ATRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adhera Therapeutics Inc (ATRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adhera Therapeutics Inc (ATRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adhera Therapeutics Inc Insider Transactions

No Available Data

Cashman Llp Pryor Mailing Address

Above is the net worth, insider trading, and ownership report for Cashman Llp Pryor. You might contact Cashman Llp Pryor via mailing address: 7 Times Square, 40th Floor, New York Ny 10036.

Discussions on Cashman Llp Pryor

No discussions yet.